Method helps identify preperimetric glaucoma

Article

The Random Forests machine learning method is a useful tool to help ophthalmologists distinguish between the visual fields (VFs) of individuals with healthy eyes and those with preperimetric open-angle glaucoma (OAG) in which glaucoma will manifest, according to research from Japan.

The Random Forests machine learning method is a useful tool to help ophthalmologists distinguish between the visual fields (VFs) of individuals with healthy eyes and those with preperimetric open-angle glaucoma (OAG) in which glaucoma will manifest, according to research from Japan published in Investigative Ophthalmology & Visual Science.

The investigators classified all VFs before an initial diagnosis of manifest glaucoma as preperimetric glaucoma VFs. They used the 30-2 threshold test programme of an automated perimeter (Humphrey Field Analyzer, Carl Zeiss Meditec) to obtain a series of 171 VFs in 53 eyes of 51 individuals with OAG or suspected OAG and from 108 healthy eyes of 87 individuals. They used the Random Forests method to calculate the area under the receiver operating characteristic curve (AROC) in distinguishing between the VFs of those with preperimetric glaucoma and those with healthy eyes; they used 52 total deviation (TD) values, mean deviation (MD) and pattern standard deviation (PSD) as predictors.

The researchers found a significant difference in MD and PSD between VFs of those with healthy eyes and the VFs of those with eyes with preperimetric glaucoma. They also observed a significant difference in the TD values between healthy VFs and preperimetric VFs at 25 out of 52 test points. The AROC obtained using the Random Forests method was 79%.

To read the study, click here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.